| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 186.523 | 177.801 | 197.571 | 228.610 | 277.283 | 400.992 | 435.440 | 493.299 | 605.531 | 755.864 |
| Total Income - EUR | 186.552 | 177.824 | 197.587 | 228.614 | 277.290 | 401.003 | 435.471 | 493.327 | 605.558 | 755.937 |
| Total Expenses - EUR | 166.822 | 164.599 | 181.145 | 211.834 | 251.426 | 351.339 | 381.739 | 434.911 | 536.681 | 694.029 |
| Gross Profit/Loss - EUR | 19.729 | 13.225 | 16.442 | 16.780 | 25.864 | 49.664 | 53.732 | 58.416 | 68.877 | 61.908 |
| Net Profit/Loss - EUR | 16.493 | 11.046 | 14.341 | 14.494 | 23.091 | 45.654 | 49.366 | 53.512 | 62.485 | 52.132 |
| Employees | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Magna Sanofarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 182 | 104 | 30 | 0 | 0 | 479 | 173 | 0 | 0 | 0 |
| Current Assets | 65.497 | 59.667 | 58.980 | 65.617 | 93.010 | 152.177 | 171.238 | 173.699 | 256.621 | 253.980 |
| Inventories | 17.472 | 18.174 | 23.433 | 22.756 | 35.953 | 55.317 | 62.169 | 66.153 | 79.908 | 97.830 |
| Receivables | 14.932 | 6.374 | 20.408 | 26.889 | 26.642 | 46.379 | 48.141 | 81.693 | 78.150 | 109.600 |
| Cash | 33.094 | 35.119 | 15.139 | 15.972 | 30.416 | 50.481 | 60.928 | 25.853 | 98.563 | 46.550 |
| Shareholders Funds | 16.538 | 11.090 | 14.384 | 14.537 | 23.134 | 45.696 | 49.406 | 53.553 | 92.144 | 52.172 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 49.290 | 48.834 | 44.747 | 51.232 | 69.890 | 106.961 | 122.004 | 120.146 | 164.478 | 201.808 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Magna Sanofarm S.r.l.